Narayana Hrudayalaya Ltd. (IN:NH)
:NH
Want to see IN:NH full AI Analyst Report?
NH Stock Chart & Stats
₹1756.45
₹14.10(1.04%)
At close: 4:00 PM EST
₹1756.45
₹14.10(1.04%)
Day’s Range― - ―
52-Week Range₹1,564.25 - ₹2,371.60
Previous CloseN/A
Volume860.19K
Average Volume (3M)80.08K
Market Cap
₹361.72B
Enterprise Value₹376.11B
Total Cash (Recent Filing)₹18.24B
Total Debt (Recent Filing)₹23.40B
Price to Earnings (P/E)75.8
Beta0.85
Next Earnings
May 15, 2026EPS Estimate
13.1Next Dividend Ex-DateN/A
Dividend Yield0.24%
Share Statistics
EPS (TTM)6.30
Shares Outstanding204,360,800
10 Day Avg. Volume19,057
30 Day Avg. Volume80,081
Financial Highlights & Ratios
PEG Ratio92.72
Price to Book (P/B)9.40
Price to Sales (P/S)6.22
P/FCF Ratio-354.49
Enterprise Value/Market CapN/A
Enterprise Value/RevenueN/A
Enterprise Value/Gross ProfitN/A
Enterprise Value/EbitdaN/A
Forecast
1Y Price Target
₹2,130.00Price Target Upside21.27% Upside
Rating ConsensusModerate Buy
Number of Analyst Covering2
EPS Forecast (FY)53.4
Revenue Forecast (FY)₹101.48B
Bulls Say, Bears Say
Bulls Say
Sustained Revenue GrowthSustained revenue growth and improved gross margins reflect expanding patient volumes and better cost control across the hospital network. Over 2–6 months this scale supports higher fixed‑cost absorption, stronger operating leverage, and more predictable earnings to fund reinvestment and service expansion.
Healthy Balance SheetA solid equity base and a manageable debt-to-equity ratio give Narayana Health durable financial flexibility. This foundation supports capital allocation for new facilities or upgrades, cushions operating volatility, and preserves access to financing on reasonable terms over the medium term.
Consistent Operating Cash GenerationConsistent operating cash flow and efficient conversion of income into cash underpin self‑funding capacity for maintenance and strategic capex. Even with a free cash flow dip tied to higher capex, steady operating cash reduces reliance on external funding for core operations and expansion.
Bears Say
Rising Total DebtAn increasing debt load over multiple years elevates leverage risk and interest obligations. If revenue growth or cash conversion weakens, higher debt can strain liquidity and capital allocation, limiting the company’s ability to invest or respond to shocks without refinancing or equity raises.
EBITDA Margin DeclineA falling EBITDA margin indicates margin pressure from rising costs or aggressive investment. Persisting margin compression would erode operating profitability and free cash generation, reducing the buffer for capital spending and limiting long‑term margin sustainability unless efficiency improves.
Negative Free Cash Flow In 2025Negative free cash flow driven by elevated capex reduces near‑term liquidity and increases dependence on external financing or balance sheet reserves. If higher capex does not translate into sustained incremental returns, prolonged negative FCF could pressure leverage and strategic flexibility.
Narayana Hrudayalaya Ltd. News
NH FAQ
What was Narayana Hrudayalaya Ltd.’s price range in the past 12 months?
Narayana Hrudayalaya Ltd. lowest stock price was ₹1564.25 and its highest was ₹2371.60 in the past 12 months.
What is Narayana Hrudayalaya Ltd.’s market cap?
Narayana Hrudayalaya Ltd.’s market cap is ₹361.72B.
When is Narayana Hrudayalaya Ltd.’s upcoming earnings report date?
Narayana Hrudayalaya Ltd.’s upcoming earnings report date is May 15, 2026 which is in 16 days.
How were Narayana Hrudayalaya Ltd.’s earnings last quarter?
Narayana Hrudayalaya Ltd. released its earnings results on Feb 13, 2026. The company reported ₹6.3 earnings per share for the quarter, missing the consensus estimate of ₹11.8 by -₹5.5.
Is Narayana Hrudayalaya Ltd. overvalued?
According to Wall Street analysts Narayana Hrudayalaya Ltd.’s price is currently Undervalued.
Does Narayana Hrudayalaya Ltd. pay dividends?
Narayana Hrudayalaya Ltd. pays a Annually dividend of ₹4.5 which represents an annual dividend yield of 0.24%. See more information on Narayana Hrudayalaya Ltd. dividends here
What is Narayana Hrudayalaya Ltd.’s EPS estimate?
Narayana Hrudayalaya Ltd.’s EPS estimate is 13.1.
How many shares outstanding does Narayana Hrudayalaya Ltd. have?
Narayana Hrudayalaya Ltd. has 204,360,800 shares outstanding.
What happened to Narayana Hrudayalaya Ltd.’s price movement after its last earnings report?
Narayana Hrudayalaya Ltd. reported an EPS of ₹6.3 in its last earnings report, missing expectations of ₹11.8. Following the earnings report the stock price went down -2.307%.
Which hedge fund is a major shareholder of Narayana Hrudayalaya Ltd.?
Currently, no hedge funds are holding shares in IN:NH
What is the TipRanks Smart Score and how is it calculated?
Smart Score combines eight research factors - such as analyst recommendations, hedge fund trends, and technical indicators - to measure a stock’s outlook. These signals are unified into a single score that reflects bullish or bearish momentum. See detailed methodology
Company Description
Narayana Hrudayalaya Ltd.
Narayana Hrudayalaya Limited provides medical and healthcare services. The company operates and maintains hospitals, clinics, health centers, nursing homes, and other related activities. It offers services in various specialties, including cardiology, cardiac surgery, nephrology, urology, neurology, neuro-surgery, endocrinology, orthopedics, internal medicines, obstetrics, gynecology, pediatrics, neonatology, gastroenterology, and oncology. As of June 30, 2022, the company operated through a network of 19 owned/operated hospitals, 2 managed hospitals, 4 heart centers, and 18 clinics and information centers in India, as well as a hospital in the Cayman Islands. It also provides healthcare consultancy services, including licensing of ERP solutions. The company was incorporated in 2000 and is headquartered in Bengaluru, India.
NH Stock 12 Month Forecast
Average Price Target
₹2,130.00
▲(21.27% Upside)
Technical Analysis
Aurobindo Pharma Ltd
―
Fortis Healthcare Ltd.
―
HealthCare Global Enterprises Ltd.
―
Krishna Institute of Medical Sciences Limited
―
Global Health Limited
―